Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

This study has been completed.
Information provided by:
Frederiksberg University Hospital Identifier:
First received: September 14, 2006
Last updated: July 3, 2007
Last verified: July 2007
ASR/Re-cap versus 28 MoM

Condition Intervention Phase
Device: ASR/Re-cap
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Pharmacokinetics/Dynamics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

Further study details as provided by Frederiksberg University Hospital:


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Clinical diagnosis of THA
  • ASA I-II
  • Willing to return for follow-up evaluations

Exclusion Criteria:

  • Collum femurs < 2 cm
  • Cysts > 1 cm
  • Caput necrose
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00376610

Frederiksberg University Hospital
Frederiksberg, Copenhagen, Denmark, 2000
Sponsors and Collaborators
Frederiksberg University Hospital
Study Director: Arne Borgwardt Frederiksberg Univesity Hospital
  More Information

No publications provided Identifier: NCT00376610     History of Changes
Other Study ID Numbers: KF1127957
Study First Received: September 14, 2006
Last Updated: July 3, 2007
Health Authority: Denmark: De Videnskabsetiske Komit'eer for Københavns og Frederiksberg Kommune processed this record on November 27, 2015